vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and NATIONAL BANKSHARES INC (NKSH). Click either name above to swap in a different company.
NATIONAL BANKSHARES INC is the larger business by last-quarter revenue ($15.3M vs $7.8M, roughly 1.9× CRYO CELL INTERNATIONAL INC). NATIONAL BANKSHARES INC runs the higher net margin — 38.5% vs -48.7%, a 87.2% gap on every dollar of revenue. On growth, NATIONAL BANKSHARES INC posted the faster year-over-year revenue change (24.7% vs -2.3%). NATIONAL BANKSHARES INC produced more free cash flow last quarter ($15.2M vs $1.2M). Over the past eight quarters, NATIONAL BANKSHARES INC's revenue compounded faster (20.9% CAGR vs -0.1%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
CCEL vs NKSH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $15.3M |
| Net Profit | $-3.8M | $5.9M |
| Gross Margin | 77.9% | — |
| Operating Margin | -50.6% | 47.4% |
| Net Margin | -48.7% | 38.5% |
| Revenue YoY | -2.3% | 24.7% |
| Net Profit YoY | -105.1% | 91.0% |
| EPS (diluted) | $-0.46 | $0.93 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $15.3M | ||
| Q3 25 | $7.8M | $14.2M | ||
| Q2 25 | $7.9M | $13.3M | ||
| Q1 25 | $8.0M | $12.8M | ||
| Q4 24 | $8.0M | $12.2M | ||
| Q3 24 | $8.1M | $11.7M | ||
| Q2 24 | $8.0M | $10.9M | ||
| Q1 24 | $7.9M | $10.4M |
| Q4 25 | $-3.8M | $5.9M | ||
| Q3 25 | $749.4K | $4.4M | ||
| Q2 25 | $355.8K | $2.3M | ||
| Q1 25 | $282.9K | $3.2M | ||
| Q4 24 | $-1.9M | $3.1M | ||
| Q3 24 | $1.1M | $2.7M | ||
| Q2 24 | $655.8K | $-307.0K | ||
| Q1 24 | $556.2K | $2.2M |
| Q4 25 | 77.9% | — | ||
| Q3 25 | 77.0% | — | ||
| Q2 25 | 76.6% | — | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 78.4% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | 73.7% | — |
| Q4 25 | -50.6% | 47.4% | ||
| Q3 25 | 24.3% | 37.9% | ||
| Q2 25 | 18.8% | 20.0% | ||
| Q1 25 | 13.3% | 30.5% | ||
| Q4 24 | -1.5% | 30.1% | ||
| Q3 24 | 17.2% | 27.5% | ||
| Q2 24 | 17.3% | -4.4% | ||
| Q1 24 | 10.5% | 25.8% |
| Q4 25 | -48.7% | 38.5% | ||
| Q3 25 | 9.6% | 31.1% | ||
| Q2 25 | 4.5% | 17.2% | ||
| Q1 25 | 3.5% | 25.3% | ||
| Q4 24 | -23.2% | 25.1% | ||
| Q3 24 | 13.0% | 22.8% | ||
| Q2 24 | 8.2% | -2.8% | ||
| Q1 24 | 7.1% | 20.8% |
| Q4 25 | $-0.46 | $0.93 | ||
| Q3 25 | $0.09 | $0.69 | ||
| Q2 25 | $0.04 | $0.36 | ||
| Q1 25 | $0.03 | $0.51 | ||
| Q4 24 | $-0.23 | $0.50 | ||
| Q3 24 | $0.13 | $0.42 | ||
| Q2 24 | $0.08 | $-0.05 | ||
| Q1 24 | $0.07 | $0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $59.3M |
| Total DebtLower is stronger | $8.4M | — |
| Stockholders' EquityBook value | $-18.6M | $184.9M |
| Total Assets | $61.7M | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $59.3M | ||
| Q3 25 | $3.2M | $42.3M | ||
| Q2 25 | $4.4M | $92.8M | ||
| Q1 25 | $3.5M | $122.5M | ||
| Q4 24 | $3.5M | $108.1M | ||
| Q3 24 | $2.1M | $49.8M | ||
| Q2 24 | $1.5M | $98.9M | ||
| Q1 24 | $979.6K | $121.2M |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | $184.9M | ||
| Q3 25 | $-14.8M | $179.2M | ||
| Q2 25 | $-15.6M | $168.7M | ||
| Q1 25 | $-14.7M | $167.3M | ||
| Q4 24 | $-13.2M | $156.4M | ||
| Q3 24 | $-9.6M | $167.8M | ||
| Q2 24 | $-10.7M | $149.0M | ||
| Q1 24 | $-10.3M | $139.4M |
| Q4 25 | $61.7M | $1.8B | ||
| Q3 25 | $63.2M | $1.8B | ||
| Q2 25 | $64.4M | $1.8B | ||
| Q1 25 | $64.4M | $1.8B | ||
| Q4 24 | $64.7M | $1.8B | ||
| Q3 24 | $62.9M | $1.8B | ||
| Q2 24 | $62.6M | $1.8B | ||
| Q1 24 | $61.7M | $1.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $17.9M |
| Free Cash FlowOCF − Capex | $1.2M | $15.2M |
| FCF MarginFCF / Revenue | 15.5% | 99.2% |
| Capex IntensityCapex / Revenue | 0.9% | 17.9% |
| Cash ConversionOCF / Net Profit | — | 3.04× |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | $23.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $17.9M | ||
| Q3 25 | $2.5M | $6.1M | ||
| Q2 25 | $707.0K | $2.1M | ||
| Q1 25 | $954.1K | $2.6M | ||
| Q4 24 | $2.2M | $9.4M | ||
| Q3 24 | $2.4M | $3.1M | ||
| Q2 24 | $1.8M | $-3.0M | ||
| Q1 24 | $-356.9K | $3.8M |
| Q4 25 | $1.2M | $15.2M | ||
| Q3 25 | $2.5M | $5.3M | ||
| Q2 25 | $644.6K | $1.5M | ||
| Q1 25 | $892.0K | $1.6M | ||
| Q4 24 | $2.1M | $6.2M | ||
| Q3 24 | $2.3M | $2.2M | ||
| Q2 24 | $21.5K | $-4.0M | ||
| Q1 24 | $-814.6K | $3.5M |
| Q4 25 | 15.5% | 99.2% | ||
| Q3 25 | 31.9% | 37.4% | ||
| Q2 25 | 8.1% | 11.5% | ||
| Q1 25 | 11.2% | 12.5% | ||
| Q4 24 | 26.8% | 50.5% | ||
| Q3 24 | 27.9% | 18.5% | ||
| Q2 24 | 0.3% | -36.3% | ||
| Q1 24 | -10.4% | 33.8% |
| Q4 25 | 0.9% | 17.9% | ||
| Q3 25 | 0.5% | 5.6% | ||
| Q2 25 | 0.8% | 4.1% | ||
| Q1 25 | 0.8% | 7.5% | ||
| Q4 24 | 0.1% | 26.6% | ||
| Q3 24 | 2.3% | 8.3% | ||
| Q2 24 | 21.8% | 9.3% | ||
| Q1 24 | 5.8% | 3.0% |
| Q4 25 | — | 3.04× | ||
| Q3 25 | 3.38× | 1.38× | ||
| Q2 25 | 1.99× | 0.90× | ||
| Q1 25 | 3.37× | 0.79× | ||
| Q4 24 | — | 3.07× | ||
| Q3 24 | 2.32× | 1.17× | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | 1.77× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
